Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer
NCT03815461
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Locally Advanced Pancreatic Cancer
Interventions
DRUG:
Nab-paclitaxel and S-1
Sponsor
Chinese Academy of Medical Sciences